07:43:12 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-29 Kvartalsrapport 2024-Q3
2024-10-15 Halvårsutdelning ORNBV 0.81
2024-10-15 Halvårsutdelning ORNAV 0.81
2024-08-08 Kvartalsrapport 2024-Q2
2024-04-25 Kvartalsrapport 2024-Q1
2024-03-21 Halvårsutdelning ORNBV 0.81
2024-03-21 Halvårsutdelning ORNAV 0.81
2024-03-20 Årsstämma 2024
2024-02-13 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-07-17 Kvartalsrapport 2023-Q2
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-23 Ordinarie utdelning ORNAV 1.60 EUR
2023-03-23 Ordinarie utdelning ORNBV 1.60 EUR
2023-03-22 Årsstämma 2023
2023-02-09 Bokslutskommuniké 2022
2022-10-20 Kvartalsrapport 2022-Q3
2022-07-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-03-24 Ordinarie utdelning ORNAV 1.50 EUR
2022-03-24 Ordinarie utdelning ORNBV 1.50 EUR
2022-03-23 Årsstämma 2022
2022-02-10 Bokslutskommuniké 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-07-19 Kvartalsrapport 2021-Q2
2021-04-27 Kvartalsrapport 2021-Q1
2021-03-26 Ordinarie utdelning ORNAV 1.50 EUR
2021-03-26 Ordinarie utdelning ORNBV 1.50 EUR
2021-03-25 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-10-21 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-05-07 Ordinarie utdelning ORNBV 1.50 EUR
2020-05-07 Ordinarie utdelning ORNAV 1.50 EUR
2020-05-06 Årsstämma 2020
2020-04-28 Kvartalsrapport 2020-Q1
2020-03-26 Ordinarie utdelning ORNBV 1.50 EUR
2020-02-05 Bokslutskommuniké 2019
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-17 Kvartalsrapport 2019-Q2
2019-04-25 Kvartalsrapport 2019-Q1
2019-03-27 Ordinarie utdelning ORNAV 1.50 EUR
2019-03-27 Ordinarie utdelning ORNBV 1.50 EUR
2019-03-26 Årsstämma 2019
2019-02-06 Bokslutskommuniké 2018
2018-10-24 Kvartalsrapport 2018-Q3
2018-07-18 Kvartalsrapport 2018-Q2
2018-04-24 Kvartalsrapport 2018-Q1
2018-03-21 Ordinarie utdelning ORNAV 1.45 EUR
2018-03-21 Ordinarie utdelning ORNBV 1.45 EUR
2018-03-20 Årsstämma 2018
2018-02-07 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-07-19 Kvartalsrapport 2017-Q2
2017-05-18 Kapitalmarknadsdag 2017
2017-04-26 Kvartalsrapport 2017-Q1
2017-03-23 Ordinarie utdelning ORNAV 1.35 EUR
2017-03-23 Bonusutdelning ORNAV 0.2
2017-03-23 Bonusutdelning ORNBV 0.2
2017-03-23 Ordinarie utdelning ORNBV 1.35 EUR
2017-03-22 Årsstämma 2017
2017-02-08 Bokslutskommuniké 2016
2016-10-25 Kvartalsrapport 2016-Q3
2016-07-19 Kvartalsrapport 2016-Q2
2016-04-27 Kvartalsrapport 2016-Q1
2016-03-23 Ordinarie utdelning ORNBV 1.30 EUR
2016-03-23 Ordinarie utdelning ORNAV 1.30 EUR
2016-03-22 Årsstämma 2016
2016-02-02 Bokslutskommuniké 2015
2015-10-27 Kvartalsrapport 2015-Q3
2015-07-28 Kvartalsrapport 2015-Q2
2015-05-26 Kapitalmarknadsdag 2015
2015-04-29 Kvartalsrapport 2015-Q1
2015-03-25 Ordinarie utdelning ORNBV 1.30 EUR
2015-03-25 Ordinarie utdelning ORNAV 1.30 EUR
2015-03-24 Årsstämma 2015
2015-02-04 Bokslutskommuniké 2014
2014-10-21 Kvartalsrapport 2014-Q3
2014-07-29 Kvartalsrapport 2014-Q2
2014-04-29 Kvartalsrapport 2014-Q1
2014-03-26 Ordinarie utdelning ORNAV 1.25 EUR
2014-03-26 Ordinarie utdelning ORNBV 1.25 EUR
2014-03-25 Årsstämma 2014
2014-02-04 Bokslutskommuniké 2013
2013-10-22 Kvartalsrapport 2013-Q3
2013-07-30 Kvartalsrapport 2013-Q2
2013-04-23 Kvartalsrapport 2013-Q1
2013-03-20 Ordinarie utdelning ORNAV 1.30 EUR
2013-03-20 Ordinarie utdelning ORNBV 1.30 EUR
2013-03-19 Årsstämma 2013
2013-02-05 Bokslutskommuniké 2012
2012-10-23 Kvartalsrapport 2012-Q3
2012-07-31 Kvartalsrapport 2012-Q2
2012-05-24 Kapitalmarknadsdag 2012
2012-04-24 Kvartalsrapport 2012-Q1
2012-03-21 Ordinarie utdelning ORNAV 1.30 EUR
2012-03-21 Bonusutdelning ORNAV 0.12
2012-03-21 Ordinarie utdelning ORNBV 1.30 EUR
2012-03-21 Bonusutdelning ORNBV 0.12
2012-03-20 Årsstämma 2012
2012-02-07 Bokslutskommuniké 2011
2011-10-25 Kvartalsrapport 2011-Q3
2011-08-02 Kvartalsrapport 2011-Q2
2011-04-27 Kvartalsrapport 2011-Q1
2011-04-01 Bonusutdelning ORNBV 0.06
2011-04-01 Bonusutdelning ORNAV 0.06
2011-04-01 Ordinarie utdelning ORNAV 1.20 EUR
2011-04-01 Ordinarie utdelning ORNBV 1.20 EUR
2011-03-31 Årsstämma 2011
2011-02-09 Bokslutskommuniké 2010
2010-10-26 Kvartalsrapport 2010-Q3
2010-08-10 Kvartalsrapport 2010-Q2
2010-04-27 Kvartalsrapport 2010-Q1
2010-03-25 Ordinarie utdelning ORNBV 1.00 EUR
2010-03-25 Bonusutdelning ORNBV 0.1
2010-03-25 Bonusutdelning ORNAV 0.1
2010-03-25 Ordinarie utdelning ORNAV 1.00 EUR
2009-03-24 Ordinarie utdelning ORNAV 0.95 EUR
2009-03-24 Ordinarie utdelning ORNBV 0.95 EUR
2008-03-26 Ordinarie utdelning ORNBV 1.00 EUR
2007-04-03 Ordinarie utdelning ORNAV 1.00 EUR
2007-04-03 Ordinarie utdelning ORNBV 1.00 EUR
2006-03-22 Ordinarie utdelning ORNBV 0.85 EUR
2005-03-22 Ordinarie utdelning ORNAV 0.55 EUR
2005-03-22 Ordinarie utdelning ORNBV 0.55 EUR
2004-09-15 Bonusutdelning ORNAV 2.14
2004-09-15 Bonusutdelning ORNBV 2.14
2004-03-23 Ordinarie utdelning ORNAV 1.60 EUR
2004-03-23 Ordinarie utdelning ORNBV 1.60 EUR
2003-12-12 Bonusutdelning ORNAV 1.5
2003-12-12 Bonusutdelning ORNBV 1.5
2003-03-23 Ordinarie utdelning ORNAV 0.93 EUR
2003-03-23 Ordinarie utdelning ORNBV 0.93 EUR
2002-04-16 Ordinarie utdelning ORNBV 1.10 EUR
2002-04-16 Ordinarie utdelning ORNAV 1.10 EUR
2001-03-30 Ordinarie utdelning ORNAV 1.20 EUR
2001-03-30 Ordinarie utdelning ORNBV 1.20 EUR
2000-03-31 Ordinarie utdelning ORNAV 1.18 EUR
2000-03-31 Ordinarie utdelning ORNBV 1.18 EUR
1999-07-28 Bonusutdelning ORNBV 13.46
1999-07-28 Bonusutdelning ORNAV 13.46
1999-04-09 Ordinarie utdelning ORNAV 6.50 EUR
1999-04-09 Ordinarie utdelning ORNBV 6.50 EUR
1998-04-21 Ordinarie utdelning ORNBV 7.50 EUR
1998-04-21 Ordinarie utdelning ORNAV 7.50 EUR
1997-04-22 Ordinarie utdelning ORNAV 5.00 EUR
1997-04-22 Ordinarie utdelning ORNBV 5.00 EUR
1996-04-23 Ordinarie utdelning ORNBV 4.00 EUR
1996-04-23 Ordinarie utdelning ORNAV 4.00 EUR

Beskrivning

LandFinland
ListaLarge Cap Helsinki
SektorHälsovård
IndustriLäkemedel & Handel
Orion är en koncern med verksamhet inom läkemedelsindustrin. Bolaget bedriver forskning och utveckling av humana- och veterinära läkemedel, där störst fokus innehas inom sjukdomar som drabbar nervsystemet, samt onkologi och luftvägssjukdomar. Idag återfinns bolagets produkter på global nivå, med störst närvaro inom Norden och övriga Europa. Bolagets huvudkontor ligger i Esbo.
2023-03-09 10:30:00

ORION CORPORATION
MANAGERS’ TRANSACTIONS
9 MARCH 2023 at 11.30 EET
        

Orion Corporation: Managers’ transactions – Kari Jussi Aho

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Kari Jussi Aho
Position: Member of the Board/Deputy member
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 26870/7/10

____________________________________________
Transaction date: 2023-03-07
Venue: CEUD
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 2 Unit price: 44.375 EUR
(2): Volume: 75 Unit price: 44.4 EUR

Aggregated transactions (2):
Volume: 77 Volume weighted average price: 44.39935 EUR
____________________________________________
Transaction date: 2023-03-07
Venue: DHEL
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 6 Unit price: 44.35 EUR

Aggregated transactions (1):
Volume: 6 Volume weighted average price: 44.35 EUR
____________________________________________
Transaction date: 2023-03-07
Venue: TQEM
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 2 Unit price: 44.375 EUR

Aggregated transactions (1):
Volume: 2 Volume weighted average price: 44.375 EUR
____________________________________________
Transaction date: 2023-03-07
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 1 Unit price: 44.35 EUR
(2): Volume: 2 Unit price: 44.35 EUR
(3): Volume: 6 Unit price: 44.35 EUR
(4): Volume: 4 Unit price: 44.35 EUR
(5): Volume: 1 Unit price: 44.4 EUR
(6): Volume: 46 Unit price: 44.4 EUR
(7): Volume: 2 Unit price: 44.4 EUR

Aggregated transactions (7):
Volume: 62 Volume weighted average price: 44.38952 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: BEUP
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 16 Unit price: 44.625 EUR
(2): Volume: 16 Unit price: 44.65 EUR
(3): Volume: 34 Unit price: 44.65 EUR

Aggregated transactions (3):
Volume: 66 Volume weighted average price: 44.64394 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: CEUX
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 41 Unit price: 44.8 EUR
(2): Volume: 40 Unit price: 44.55 EUR
(3): Volume: 42 Unit price: 44.55 EUR

Aggregated transactions (3):
Volume: 123 Volume weighted average price: 44.63333 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: DHEL
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 8 Unit price: 44.375 EUR
(2): Volume: 75 Unit price: 44.275 EUR
(3): Volume: 3 Unit price: 44.275 EUR
(4): Volume: 35 Unit price: 44.275 EUR

Aggregated transactions (4):
Volume: 121 Volume weighted average price: 44.28161 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: TQEM
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 63 Unit price: 44.65 EUR
(2): Volume: 234 Unit price: 44.475 EUR
(3): Volume: 69 Unit price: 44.35 EUR
(4): Volume: 191 Unit price: 44.35 EUR

Aggregated transactions (4):
Volume: 557 Volume weighted average price: 44.43645 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: TQEX
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 41 Unit price: 44.55 EUR

Aggregated transactions (1):
Volume: 41 Volume weighted average price: 44.55 EUR
____________________________________________
Transaction date: 2023-03-08
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009014369
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 32 Unit price: 44.8 EUR
(2): Volume: 144 Unit price: 44.7 EUR
(3): Volume: 1 Unit price: 44.65 EUR
(4): Volume: 3 Unit price: 44.65 EUR
(5): Volume: 150 Unit price: 44.65 EUR
(6): Volume: 299 Unit price: 44.55 EUR
(7): Volume: 35 Unit price: 44.35 EUR
(8): Volume: 55 Unit price: 44.35 EUR
(9): Volume: 65 Unit price: 44.45 EUR
(10): Volume: 10 Unit price: 44.45 EUR
(11): Volume: 29 Unit price: 44.45 EUR
(12): Volume: 150 Unit price: 44.45 EUR
(13): Volume: 9 Unit price: 44.45 EUR
(14): Volume: 150 Unit price: 44.45 EUR
(15): Volume: 11 Unit price: 44.4 EUR
(16): Volume: 150 Unit price: 44.4 EUR
(17): Volume: 13 Unit price: 44.4 EUR
(18): Volume: 150 Unit price: 44.4 EUR
(19): Volume: 17 Unit price: 44.35 EUR
(20): Volume: 150 Unit price: 44.35 EUR
(21): Volume: 150 Unit price: 44.35 EUR
(22): Volume: 150 Unit price: 44.35 EUR
(23): Volume: 9 Unit price: 44.35 EUR
(24): Volume: 18 Unit price: 44.35 EUR
(25): Volume: 150 Unit price: 44.35 EUR
(26): Volume: 9 Unit price: 44.35 EUR
(27): Volume: 150 Unit price: 44.35 EUR
(28): Volume: 2 Unit price: 44.35 EUR
(29): Volume: 18 Unit price: 44.3 EUR
(30): Volume: 8 Unit price: 44.3 EUR
(31): Volume: 11 Unit price: 44.3 EUR
(32): Volume: 1 Unit price: 44.3 EUR
(33): Volume: 2 Unit price: 44.3 EUR
(34): Volume: 5 Unit price: 44.3 EUR
(35): Volume: 12 Unit price: 44.3 EUR
(36): Volume: 99 Unit price: 44.3 EUR
(37): Volume: 19 Unit price: 44.3 EUR
(38): Volume: 9 Unit price: 44.3 EUR

Aggregated transactions (38):
Volume: 2445 Volume weighted average price: 44.43961 EUR

Orion Corporation

Liisa Hurme

President and CEO
   Olli Huotari

SVP, Corporate Functions
 

                                                

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.